Esta web utiliza cookies propias y de terceros que nos permiten optimizar tu experiencia en el sitio web, evaluar su rendimiento, generar estadísticas de uso y mejorar y añadir nuevas funcionalidades. Mediante el análisis de tus hábitos de navegación podemos mostrar contenidos más relevantes y medir las interacciones con la web.
Puede obtener más información aquí.

Avanzado
Artículos
Portada

DECODING PROTEIN INTERACTION NETWORKS IBD

SAHU INDRAJIT
MEEM PUBLISHERS
07 / 2023
9789631635829
Inglés

Sinopsis

Aims to unravel the functional importance of protein interaction networks facilitated by the 19S regulatory particle of the proteasome. The proteasome is a crucial cellular machinery responsible for protein degradation, playing a vital role in maintaining cellular homeostasis and regulating various cellular processes. The 19S regulatory particle is a key component that recognizes and processes ubiquitinated proteins, guiding them to the core proteolytic chamber for degradation.In this research, the scientists investigate the specific protein-protein interactions that occur with the 19S regulatory particle. By elucidating these interactions, the researchers seek to understand how the 19S particle regulates and selects target proteins for degradation, shedding light on the underlying molecular mechanisms.To achieve this, the study likely involves a combination of experimental techniques such as co-immunoprecipitation, yeast two-hybrid assays, mass spectrometry, and advanced computational approaches for data analysis. Through these methods, the researchers can identify the proteins that directly interact with the 19S regulatory particle and form complex networks within the cell.The findings of this research have the potential to provide valuable insights into the complex regulation of protein degradation and its implications in various cellular processes, including cell cycle control, DNA repair, immune response, and protein quality control. Moreover, a deeper understanding of these protein interaction networks could pave the way for the development of targeted therapies to manipulate proteasomal activity, potentially offering new treatment strategies for various diseases, including cancer and neurodegenerative disorders.